Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

TNS Energy Group reported for 9 months of 2024 by RAS

11/2/24 TNSE

TNS Energo Rostov-on-Don reported for 9 months of 2024 by RAS

11/2/24 RTSB

TNS Energo Mari El reported for 9 months of 2024 by RAS

11/2/24 MISB

TNS Energo Voronezh reported for 9 months of 2024 by RAS

11/2/24 VRSB

TNS Energo Yaroslavl reported for 9 months of 2024 by RAS

11/2/24 YRSB

TNS Energo Nizhny Novgorod reported for 9 months of 2024 by RAS

11/2/24 NNSB

Kamaz reported for 9 months of 2024 by RAS

11/2/24 KMAZ

TNS Energy Kuban reported for 9 months of 2024 by RAS

11/2/24 KBSB

Sollers reported for 9 months of 2024 by RAS

11/2/24 SVAV

Buryatzoloto reported for 9 months of 2024 by RAS

11/2/24 BRZL